These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 6371386

  • 1. Prostacyclin bioassays using inhibition of platelet aggregation and relaxation of rabbit coeliac artery.
    Fournau P, Bonnet P, Bourgue MF, Paris J.
    J Pharmacol Methods; 1984 Mar; 11(1):53-60. PubMed ID: 6371386
    [Abstract] [Full Text] [Related]

  • 2. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
    Lidbury PS, Antunes E, de Nucci G, Vane JR.
    Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103
    [Abstract] [Full Text] [Related]

  • 3. Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.
    Vane JR.
    Postgrad Med J; 1983 Dec; 59(698):743-58. PubMed ID: 6361717
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological properties of MM-706, a new prostacyclin derivative.
    Ragazzi E, Chinellato A, Lille U, Lopp M, Doni MG, Fassina G.
    Gen Pharmacol; 1995 Jul; 26(4):703-9. PubMed ID: 7635245
    [Abstract] [Full Text] [Related]

  • 5. The relaxing activity of iloprost and prostaglandin E2 in the isolated various smooth muscle strips of the rabbit.
    Ercan ZS, Türker RK.
    Pharmacology; 1985 Jul; 31(2):61-6. PubMed ID: 2410937
    [Abstract] [Full Text] [Related]

  • 6. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
    Omini C, Moncada S, Vane JR.
    Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
    [Abstract] [Full Text] [Related]

  • 7. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 8. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
    Malomvölgyi B, Hadházy P, Magyar K, Kánai K, Simonidesz V.
    Acta Physiol Acad Sci Hung; 1982 Jul; 60(4):251-6. PubMed ID: 6764858
    [Abstract] [Full Text] [Related]

  • 9. Quantitation by bioassay of mixtures of prostaglandins E2 and I2.
    Lukacsko P, Roberts AM, Messina EJ, Kaley G.
    Prostaglandins Med; 1980 Mar; 4(3):171-6. PubMed ID: 6994156
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R, Grossoni M, Ukmar G, Colombo M, Mongelli N.
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of PGI2 and two analogues (FCE 21292 and FCE 21258) in vitro and in vivo.
    Morley J, Page CP, Paul W, Mongelli N, Ceserani R, Gandolfi C.
    Prostaglandins Leukot Med; 1983 Aug; 11(4):391-9. PubMed ID: 6353424
    [Abstract] [Full Text] [Related]

  • 12. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A, Folco GC, Fumagalli R, Nicosia S, Noe MA, Oliva D.
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [Abstract] [Full Text] [Related]

  • 13. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
    Ceserani R, Grossoni M, Longiave D, Mizzotti B, Pozzi O, Dembinska-Kiec A, Bianco S.
    Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T, Satoh K, Nishimura T, Horikawa N, Mine T, Hirohashi T, Hara Y.
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [Abstract] [Full Text] [Related]

  • 15. [Prostacyclin in cardiovascular diseases].
    Kishi Y, Numano F.
    Kokyu To Junkan; 1985 Jul; 33(7):865-9. PubMed ID: 3903901
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M.
    Pol J Pharmacol Pharm; 1982 Jul; 34(5-6):317-21. PubMed ID: 6821216
    [Abstract] [Full Text] [Related]

  • 17. A new stable prostacyclin mimic, 7-oxoprostaglandin I2.
    Kovács G, Simonidesz V, Tömösközi I, Körmöczy P, Székely I, Papp-Behr A, Stadler I, Szekeres L, Papp G.
    J Med Chem; 1982 Feb; 25(2):105-7. PubMed ID: 7035669
    [No Abstract] [Full Text] [Related]

  • 18. Hypoventilation and elevation of end-expiratory pressure release a substance which relaxes isolated arteries and disaggregates platelets in the presence of cyclooxygenase inhibitors.
    Herbaczynska-Cedro K, Truskolaski P, Huszczuk A, Dusting GJ.
    Prostaglandins; 1981 May; 21(5):707-17. PubMed ID: 7041193
    [Abstract] [Full Text] [Related]

  • 19. Relaxation of human isolated pulmonary arteries by prostacyclin (PGI2).
    Hadházy P, Vizi ES, Magyar K, Debreczeni LA, Hutás I.
    Lung; 1983 May; 161(2):123-30. PubMed ID: 6341718
    [No Abstract] [Full Text] [Related]

  • 20. Platelet and other effects of carboprostacyclin--a stable prostacyclin analogue.
    Adaikan PG, Karim SM, Lau LC.
    Prostaglandins Med; 1980 Oct; 5(4):307-20. PubMed ID: 7003626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.